An Unusual Clinical Presentation of Merkel Cell Carcinoma: A Case Report by Sarma, Deba P. et al.
Hindawi Publishing Corporation
Case Reports in Medicine
Volume 2010, Article ID 905414, 3 pages
doi:10.1155/2010/905414
Case Report
An Unusual Clinical Presentation of Merkel Cell Carcinoma:
AC a s eR e po rt
DebaP. Sarma,1 DawnE.Heagley,1 JulianneChalupa,1
Meredith Cox,1 and James M. Shehan2
1Department of Pathology, Creighton University Medical Center (DPS, DEH, JC, MC), Omaha,
NE 68131, USA
2Department of Dermatology (JMS), Bergan Mercy Medical Center, Omaha, NE 68124, USA
C o r r e s p o n d e n c es h o u l db ea d d r e s s e dt oD e b aP .S a r m a ,debasarma@creighton.edu
Received 26 November 2009; Revised 6 February 2010; Accepted 8 February 2010
Academic Editor: Jochen Utikal
Copyright © 2010 Deba P. Sarma et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Introduction. Merkel cell carcinoma is a rare, aggressive neuroendocrine cell carcinoma arising in the sun-exposed skin of elderly
patients. Most of these tumors are located in the dermis. An unusual clinical presentation of such a tumor in the subcutis, if not
biopsied,maybeeasilymistakenasabenignlesion.CasePresentation.An83-year-oldwhitewomanpresentedwithaseveral-month
history of a painless 7mm subcutaneous mass that was initially thought to be a lipoma. A conservative follow-up was planned.
At the insistence of the patient, an excisional biopsy of the mass was performed revealing a subcutaneous Merkel cell carcinoma.
The tumor cells stained positively for CK 20, chromogranin, and synaptophysin. No other primary or metastatic tumors found
after a thorough work-up. The patient was treated with local irradiation. She remains disease free at her six-month follow-up visit.
Conclusion. When a new growth is encountered in the sun-exposed skin of elderly patients, a biopsy is warranted even if the lesion
clinically appears benign.
1. Case Presentation
An 83-year-old white American woman of European descent
presented to the Dermatology clinic complaining of a small
painless “lump” on her left cheek that had been present
for several months. She did not have a past history of any
signiﬁcant medical illness including any neoplastic disease.
Physical examination revealed a 7mm soft papule with
overlying intactskin on theleftcheek. Therewasnoevidence
of any sun-induced skin lesion. There were no palpable
lymph nodes in the neck. Clinical impression was that
of a benign subcutaneous nodule such as a lipoma. The
patientwasadvisedofconservativefollow-up,butthepatient
insisted on having the lesion removed.
An excisional biopsy was performed. The excised spec-
imen was an ovoid fragment of adipose tissue measuring
1cm in size attached to an ellipse of normal skin measuring
1.9×0.5cm.
Microscopic examination revealed an intact atrophic
epidermis, solar elastosis of the dermis, and several dark
tumor nodules in the subcutaneous adipose tissue (Figures
1 and 2). The neoplasm was composed of dark, small
undiﬀerentiated cells with ill-deﬁned cell borders showing
large hyperchromatic nuclei with numerous mitotic ﬁgures
(Figure 3). The tumor cells stained positively for CK 20
showinga“dot-like”pattern(Figure 4)andwerealsopositive
for chromogranin (Figure 5) and synaptophysin (Figure 6).
They were negative for CK 5/6, S-100, and LCA immunos-
tains. The diagnosis of subcutaneous Merkel cell carcinoma
(MCC) was made.
A thorough clinical and radiological workup was under-
taken to exclude other possible primary neuroendocrine
carcinomas, especially that of lung. The patient was found
to be free of other primary or metastatic tumors.
The patient refused surgical intervention and was treated
with local irradiation at the biopsy site. At the six-month2 Case Reports in Medicine
Figure 1: Dermal solar degeneration and dark tumor nodule in the
subcutaneous tissue.
Figure 2: Undiﬀerentiated dark epitheliod neoplastic inﬁltrates
within the adipose tissue.
Figure 3: The neoplastic cells show vague cell borders, large pleo-
morphic nuclei, and numerous mitotic ﬁgures.
Figure 4: The tumor cells are positive for CK20 and show a “dot-
like” pattern of staining.
Figure 5: The tumor cells are positive for chromogranin.
Figure 6: The tumor cells are positive for synaptophysin.Case Reports in Medicine 3
follow-up visit, the patient remains asymptomatic and free
of tumor.
2. Discussion
Merkel cell carcinoma (MCC) is a rare, aggressive cutaneous
carcinoma arising from neuroendocrine cells of the dermis.
Clinically, MCC is found in sun-exposed areas such as the
face or neck and presents as a small (less than 2cm), red or
violet raised nodule with intact overlying skin. The lesion is
usually painless and rapidly growing. The populations most
commonly aﬀected are Caucasians over the age of 70 and the
immunosuppressed [1–4].
Microscopically, the tumor nodule of MCC is comprised
of small cells with scant cytoplasm, large nuclei, ﬁnely
granular chromatin, and numerous mitotic ﬁgures. MCC
is best diﬀerentiated from other cutaneous tumors by
immunohistochemical stains. MCC cells stain positively for
cytokeratin 20 in a characteristic “dot-like” pattern and
stain negatively for S-100 (positive in melanoma), TTF-1
and CK7, (positive in small cell lung carcinoma), and LCA
(positive in lymphoma) [4]. Additionally, MCC cells stain
positively for neuroendocrine markers chromogranin and
synaptophysin. Electron microscopy shows characteristic
intracytoplasmic neurosecretory granules [1].
Merkel cell carcinoma almost always arises in the dermis,
but there has been one reported case in the literature of
MCCarising in subcutaneousfat[2]. Ourcase representsthe
second reported case, to our knowledge, of MCC arising in
subcutaneous adipose tissue.
Treatment of MCC includes wide excision, sentinel
lymph node biopsy, and local radiation. Neoadjuvant
chemotherapy is not recommended. Prognosis is variable
and most dependent on stage of disease at presentation.
Overall, local recurrence after excision occurs in about 40
percentofcases,whileregionallymphnodemetastasisoccurs
in about 30 percent of patients [4].
Identiﬁed risk factors associated with MCC are: age
greater than 50 years, European ancestry, ultraviolet (UV)
radiation, immunocompromised state, or infection with
Merkel Cell Polyomavirus (MCPyV). Frequency of MCC
increases dramatically in patients after the age of 50 years
suggesting an accumulation of oncogenic events. Regarding
UV radiation, MCC tumors are present in sun-exposed areas
such as the head and neck. Patients who have undergone
prior psoralen and PUVA treatment are at higher incidence.
Those of European decent are genetically more susceptible
to this radiation and therefore have an increased prevalence
of MCC. An association is also noted in patients who are
immunocompromised; an 11-fold increase in incidence of
MCC has been seen in patients with AIDS and a 5-fold
increase in patients who have undergone organ transplan-
tation. Finally, a correlation between MCPyV and MCC has
been established [5, 6].
Recentresearchhasstrengthenedthecorrelationbetween
MCPyV and MCC. MCPyV DNA is found in the majority
of MCC tumors but is also commonly found in normal
tissue including saliva and tissues of the upper digestive
tract. A recent study suggests that the MCPyV integrates
into the Large T antigen prior to clonal expansion, and this
interruption of the Large T antigen is not seen in nontumor
cells [5]. Another study indicates that lower mortality of
MCC is associated with MCPyV viral integration versus
those MCCs without MCPyV [6]. This data suggests the
possibilityofdiﬀerentmechanismsforinducingoncogenesis.
MCPyV DNA is ubiquitous in nature and MCC is relatively
rare suggesting that this may be one of many cofactors
involved in the oncogenic transformation to MCC.
3. Conclusion
When a new growth is encountered in the sun-exposed skin
of elderly patients, a biopsy is warranted even if the lesion
clinically appears benign.
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